Long-term risk of breast cancer in women with fibroadenoma. Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD, Rados MS, Schuyler PA (1994) N Engl J Med 331: 10-5 Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. Xie D, Shu XO, Deng Z, Wen WQ, Creek KE, Dai Q, Gao YT, Jin F, Zheng W (2000) J Natl Cancer Inst 92: 412-7 Estrogen replacement therapy in women with a history of proliferative breast disease. Dupont WD, Page DL, Parl FF, Plummer WD, Schuyler PA, Kasami M, Jensen RA (1999) Cancer 85: 1277-83 No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia. Carter BA, Page DL, Schuyler P, Parl FF, Simpson JF, Jensen RA, Dupont WD (2001) Cancer 92: 30-6 Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics. Dai Q, Franke AA, Yu H, Shu XO, Jin F, Hebert JR, Custer LJ, Gao YT, Zheng W (2003) Cancer Epidemiol Biomarkers Prev 12: 497-502 Monoclonality in fibroadenomas with complex histology and phyllodal features. Kasami M, Vnencak-Jones CL, Manning S, Dupont WD, Jensen RA, Page DL (1998) Breast Cancer Res Treat 50: 185-91 Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease. Li X, Huang W, Yankeelov TE, Tudorica A, Rooney WD, Springer CS (2005) Magn Reson Med 53: 724-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.